Access
使用权
基本信息
- 批准号:8377955
- 负责人:
- 金额:$ 22.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-20 至
- 项目状态:未结题
- 来源:
- 关键词:AcuteAlteplaseBrain hemorrhageCaringClinicalClinical ResearchClinical TrialsCollaborationsCommunitiesConsultDataEmergency MedicineEnrollmentEvaluationFDA approvedFacultyFutureGoalsGrantHealthHealthcareHealthcare SystemsHospitalsHourImageInterventionIntravenousInvestigationIschemic StrokeLeadershipMassachusettsMeasuresMonitorNeurologyNursesOutcomePatient CarePatient SelectionPatientsPhysiciansPositioning AttributeProcessProtocols documentationPublic HealthRadiology SpecialtyRecoveryResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsServicesSiteSolutionsStrokeSystemTestingThrombolytic TherapyTrainingTranslational ResearchUniversitiesWomanacute strokecare deliveryclinical careclinical practicedisabling diseaseexperienceimprovedmeetingsmemberneurosurgeryprogramsthrombolysis
项目摘要
The Access Core ofthe SPOTRIAS center at Partners will confinue to support the rapid administrafion of standard intravenous thrombolysis, the rapid evaluation and treatment of hemorrhagic stroke, as well as the execution of the four proposed research projects (two independent Partners projects and two collaborative projects with Columbia University) at the hwo Partners academic centers. The Access Core will also strive to increase its impact on stroke in the broader community by extending its acute stroke expertise within and across our extensive nehwork of Partners Healthcare System (PHS) and 26 TeleStroke-affiliated hospitals.
This will help provide a platform from which to launch future SPOTRIAS network-wide stroke research. For the last two decades. Partners has enjoyed a rich clinical and research collaboration involving the Departments of Emergency Medicine, Radiology, Neurology, and Neurosurgery. The leadership of the Access Core reflects the integrated approach to acute stroke care across the system. The Access Core is co-directed by physicians from Neurology and Emergency Medicine who are institutional leaders in quality improvement, with addifional key leadership posifions held by active members of these departments at each site, all of whom care for acute stroke pafients in their clinical practice. In addifion, the two hospitals use the same acute stroke protocols, share the same acute stroke and NICU fellows and collaborate on the same acute stroke quality agenda. The Partners SPOTRIAS program is fully integrated into the daily activities of the clinical stroke care and stroke research activities at the two sites, and the Access Core is uniquely positioned to accomplish its goals because so many of the SPOTRIAS research faculties are also active members ofthe acute stroke clinical care delivery team. In pursuit of its aims, the Access Core will utilize the
robust quality improvement infrastructure which Dr. Schwamm has developed across Partners for continued advancement of acute stroke care for patients within the broader context of a coordinated regional stroke network.
Partners 的 SPOTRIAS 中心的 Access Core 将继续支持标准静脉溶栓的快速管理、出血性中风的快速评估和治疗,以及 hwo Partners 学术中心的四个拟议研究项目(两个独立的 Partners 项目和两个与哥伦比亚大学的合作项目)的执行。 Access Core 还将通过在我们的合作伙伴医疗保健系统 (PHS) 和 26 家 TeleStroke 附属医院的广泛网络内部和之间扩展其急性中风专业知识,努力提高其对更广泛社区中风的影响。
这将有助于提供一个平台来启动未来 SPOTRIAS 网络范围内的中风研究。过去二十年来。合作伙伴享有丰富的临床和研究合作,涉及急诊医学、放射科、神经病学和神经外科。 Access Core 的领导地位体现了整个系统对急性中风护理的综合方法。 Access Core 由来自神经病学和急诊医学的医生共同领导,他们是质量改进方面的机构领导者,其他关键领导职位由每个中心这些部门的活跃成员担任,他们都在临床实践中护理急性中风患者。此外,两家医院使用相同的急性卒中方案,共享相同的急性卒中和 NICU 研究员,并在相同的急性卒中质量议程上进行合作。合作伙伴 SPOTRIAS 计划完全融入两个地点的临床中风护理和中风研究活动的日常活动,并且 Access Core 处于实现其目标的独特位置,因为许多 SPOTRIAS 研究人员也是急性中风临床护理提供团队的积极成员。为了实现其目标,Access Core 将利用
Schwamm 博士在合作伙伴中开发了强大的质量改进基础设施,以便在协调的区域卒中网络的更广泛背景下持续推进对患者的急性卒中护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lee H Schwamm其他文献
Breaking up is hard to do: tenecteplase in acute stroke
分手很难做到:替奈普酶治疗急性中风
- DOI:
10.1016/s1474-4422(15)70036-0 - 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Lee H Schwamm - 通讯作者:
Lee H Schwamm
Lee H Schwamm的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lee H Schwamm', 18)}}的其他基金
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
9753384 - 财政年份:2018
- 资助金额:
$ 22.67万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
9571496 - 财政年份:2018
- 资助金额:
$ 22.67万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
10306037 - 财政年份:2018
- 资助金额:
$ 22.67万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
9343382 - 财政年份:2016
- 资助金额:
$ 22.67万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
8662842 - 财政年份:2013
- 资助金额:
$ 22.67万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
8890256 - 财政年份:2013
- 资助金额:
$ 22.67万 - 项目类别:
New England Regional Coordinating Center for the NINDS Stroke Trials Network
NINDS 卒中试验网络新英格兰地区协调中心
- 批准号:
8738738 - 财政年份:2013
- 资助金额:
$ 22.67万 - 项目类别:
相似海外基金
AcT-Cog: Online cognitive assessment in the Alteplase compared to Tenecteplase (AcT) trial.
AcT-Cog:阿替普酶与替奈普酶 (AcT) 试验相比的在线认知评估。
- 批准号:
444794 - 财政年份:2021
- 资助金额:
$ 22.67万 - 项目类别:
Operating Grants
INTERRAcT: Thrombus characteristics for predicting Reperfusion with Alteplase compared to Tenecteplase
INTERRAcT:与替奈普酶相比,阿替普酶预测再灌注的血栓特征
- 批准号:
433102 - 财政年份:2020
- 资助金额:
$ 22.67万 - 项目类别:
Operating Grants
Alteplase Compared to Tenecteplase in patients with Acute Ischemic Stroke: QuICR & OPTIMISE Registry based Pragmatic Randomized Controlled Trial
阿替普酶与替奈普酶治疗急性缺血性中风患者的比较:QuICR
- 批准号:
401715 - 财政年份:2019
- 资助金额:
$ 22.67万 - 项目类别:
Operating Grants
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial
替奈普酶与阿替普酶用于中风溶栓评估 (TASTE) 试验
- 批准号:
nhmrc : 1079696 - 财政年份:2015
- 资助金额:
$ 22.67万 - 项目类别:
Project Grants
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation (TASTE) Trial
替奈普酶与阿替普酶用于中风溶栓评估 (TASTE) 试验
- 批准号:
nhmrc : GNT1079696 - 财政年份:2015
- 资助金额:
$ 22.67万 - 项目类别:
Project Grants
Low-Dose Tenecteplase vs Standard-Dose Alteplase for Acute Ischaemic Stroke: An Imaging Based Safety and Efficacy Study
低剂量替奈普酶与标准剂量阿替普酶治疗急性缺血性中风:一项基于影像学的安全性和有效性研究
- 批准号:
nhmrc : 510722 - 财政年份:2008
- 资助金额:
$ 22.67万 - 项目类别:
NHMRC Project Grants
Treatment of Deep Vein Thrombosis of the Lower Extremities w/Low Dose Alteplase
小剂量阿替普酶治疗下肢深静脉血栓
- 批准号:
8565339 - 财政年份:
- 资助金额:
$ 22.67万 - 项目类别:
Treament of Deep Vein Thrombosis of the Lower Extremities w/Low Dose Alteplase
小剂量阿替普酶治疗下肢深静脉血栓
- 批准号:
7593114 - 财政年份:
- 资助金额:
$ 22.67万 - 项目类别:
Treatment of Deep Vein Thrombosis of the Lower Extremities w/Low Dose Alteplase
小剂量阿替普酶治疗下肢深静脉血栓
- 批准号:
8952839 - 财政年份:
- 资助金额:
$ 22.67万 - 项目类别:














{{item.name}}会员




